Complete and Durable Response to Combined Chemo/Radiation Therapy in EGFR Wild-Type Lung Adenocarcinoma with Diffuse Brain Metastases

Most non-small-cell lung cancer (NSCLC) patients are likely to develop brain metastases during the course of their illness. Currently, no consensus on NSCLC patients’ treatment with brain metastasis has been established. Although whole brain radiotherapy prolongs the median survival time of approxim...

Descripción completa

Detalles Bibliográficos
Autores principales: Santeufemia, Davide Adriano, Palmieri, Giuseppe, Cossu, Antonio, De Re, Valli, Caggiari, Laura, De Zorzi, Mariangela, Casula, Milena, Sini, Maria Cristina, Baldino, Giovanni, Dedola, Maria Filomena, Corona, Giuseppe, Miolo, Gianmaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627459/
https://www.ncbi.nlm.nih.gov/pubmed/30979070
http://dx.doi.org/10.3390/diagnostics9020042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627459/
https://www.ncbi.nlm.nih.gov/pubmed/30979070
http://dx.doi.org/10.3390/diagnostics9020042

Ejemplares similares